BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33376376)

  • 41. Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.
    Mason JM; Carr J; Buckley C; Hewitt S; Berry P; Taylor J; Cork MJ
    BMC Dermatol; 2013 May; 13():7. PubMed ID: 23679991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness.
    Santer M; Ridd MJ; Francis NA; Stuart B; Rumsby K; Chorozoglou M; Becque T; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas KS; Thomas-Jones E; Williams HC; Little P
    BMJ; 2018 May; 361():k1332. PubMed ID: 29724749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of a Novel Generation of Emollients, 'Emollients Plus', in Atopic Dermatitis.
    Araviiskaia E; Pincelli C; Sparavigna A; Luger T
    Clin Cosmet Investig Dermatol; 2022; 15():2705-2719. PubMed ID: 36545500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of topical therapy in the maintenance of atopic dermatitis remission in pediatric age.
    Pecoraro L; Florile M; Piazza M; Comberiati P; Clemente M; Tadiotto E; Pietrobelli A; Piacentini G
    Minerva Pediatr (Torino); 2021 Aug; 73(4):294-300. PubMed ID: 29968448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bath emollients for atopic eczema: why use them?
    Drug Ther Bull; 2007 Oct; 45(10):73-5. PubMed ID: 17928284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.
    Santer M; Rumsby K; Ridd MJ; Francis NA; Stuart B; Chorozoglou M; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas-Jones E; Becque T; Thomas KS; Williams HC; Little P
    Health Technol Assess; 2018 Oct; 22(57):1-116. PubMed ID: 30362939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of an Emollient on the Mycobiome of Atopic Dermatitis Patients.
    Chandra J; Retuerto M; Seité S; Martin R; Kus M; Ghannoum MA; Baron E; Mukherjee PK
    J Drugs Dermatol; 2018 Oct; 17(10):1039-1048. PubMed ID: 30365583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis.
    Glatz M; Jo JH; Kennedy EA; Polley EC; Segre JA; Simpson EL; Kong HH
    PLoS One; 2018; 13(2):e0192443. PubMed ID: 29489859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating emollient usage in patients with eczema.
    Hon KL; Ching GK; Leung TF; Choi CY; Lee KK; Ng PC
    Clin Exp Dermatol; 2010 Jan; 35(1):22-6. PubMed ID: 19489850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment.
    Seite S; Flores GE; Henley JB; Martin R; Zelenkova H; Aguilar L; Fierer N
    J Drugs Dermatol; 2014 Nov; 13(11):1365-72. PubMed ID: 25607704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The improvement of infantile atopic dermatitis during the maintenance period: A multicenter, randomized, parallel controlled clinical study of emollients in Prinsepia utilis Royle.
    Wang S; Wang L; Li P; Shu H; Shen C; Wu Y; Luo Z; Miao L; Wang H; Jiao L; Tian J; Peng X; Zhao M; Liu Y; Nie X; He L; Ma L
    Dermatol Ther; 2020 Mar; 33(2):e13153. PubMed ID: 31705602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient.
    Gelmetti C; Boralevi F; Seité S; Grimalt R; Humbert P; Luger T; Stalder JF; Taïeb A; Tennstedt D; Garcia Diaz R; Rougier A
    Pediatr Dermatol; 2012; 29(6):714-8. PubMed ID: 23106672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.
    Skjerven HO; Rehbinder EM; Vettukattil R; LeBlanc M; Granum B; Haugen G; Hedlin G; Landrø L; Marsland BJ; Rudi K; Sjøborg KD; Söderhäll C; Staff AC; Carlsen KH; Asarnoj A; Bains KES; Carlsen OCL; Endre KMA; Granlund PA; Hermansen JU; Gudmundsdóttir HK; Hilde K; Håland G; Kreyberg I; Olsen IC; Mägi CO; Nordhagen LS; Saunders CM; Skrindo I; Tedner SG; Værnesbranden MR; Wiik J; Jonassen CM; Nordlund B; Carlsen KCL
    Lancet; 2020 Mar; 395(10228):951-961. PubMed ID: 32087121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
    Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
    Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis.
    Chiang C; Eichenfield LF
    Pediatr Dermatol; 2009; 26(3):273-8. PubMed ID: 19706087
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.